IDO2 and colitis: Intraperitoneal administration of TLR3 polyI:C activated MSC further reduced disease severity in mice with DSS-induced colitis through enhanced immunosuppressive activity by stimulating MSCs to increase production of indoleamine 2,3-dioxygenase (IDO) [82].